RxDoctor Payments Data

Monica Rhodes, APRN

Gerontology · Lawton, OKNPI 1578087243

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 91.5% of the total across 192 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 47 manufacturers, the largest accounting for just 9.0% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,200, more than ten times the $27 reported in 2021.

$4,066in general payments, 2019–2025

Across 192 payments — averaging $21.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$364
  • Amgen$340
  • Novartis$311
  • Incyte Corporation$234
  • Seagen Inc.$225
  • Sanofi$220
  • plus $2K from 41 others

What the payments were for

  • Food & beverage$3,71991%
  • Education$3479%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,066 in reported general payments places this provider in the 80th percentile of 73 gerontology providers in Oklahoma.

See all gerontology providers in Oklahoma

Medicare billing

Part B allowed, 2024
$13,907
Medicare patients
173
Services billed
203

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Prochlorperazine Maleate77$1,709
Ondansetron OdtOndansetron74$1,124
Lidocaine-PrilocaineLidocaine/Prilocaine75$1,005
Letrozole11$345
Dexamethasone20$324
Levothyroxine Sodium12$102
Prednisone12$49

Paid to pharmacies, not to this prescriber.

Other gerontology in Lawton

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →